Ovarian cancer
Results
Phase 2
This trial looked at using gatipotuzumab after chemotherapy for that had come back.
It was for women with ovarian cancer, fallopian tube cancer or primary peritoneal cancer. These cancers are treated in a similar way. When we use the term ovarian cancer in this summary, we are referring to all 3.
Women could join the trial between 2013 and 2016. The team published the results in 2022.
Gatipotuzumab is pronounced gat-i-poe-too-zoo-mab.
Recruitment start: 1 November 2013
Recruitment end: 31 October 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Jonathan Ledermann
Glycotope
Last reviewed: 17 Jul 2026
CRUK internal database number: 13406
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
